B7H3-specific CAR T cells with a humanized antigen recognition structural domain could effectively kill gastric cancer cells while targeting cancer stem cells to improve immune therapy efficacy, which was considered a potential strategy to treat gastric cancer (77). Here, CD276 is linked to gastric cancer.